<span dir="ltr">EG</span>-018 is a carbazole-based synthetic cannabinoid that has been sold online as a designer drug. It acts as a partial agonist of the CB<sub>1</sub> and CB<sub>2</sub> receptor, with reasonably high binding affinity, but low efficacy in terms of inducing a signaling response.
EG-018 is a controlled substance in Japan.